ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BAXNovember 10, 2025 7:36 PM EST | Source: The Rosen Law Firm PANew York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Baxter International Inc. (NYSE: BAX) between February 23, 2022 and July 30, 2025, both dates inclusive (the "Class Period") ...

Nov 10, 2025 7:00 PM Eastern Standard Time Surmodics Announces U.S. District Court Denies Request for Preliminary Injunction to Block Proposed Acquisition by GTCR Share EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX) ("Surmodics†or the "Company†), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that the United States District Court for the Northern District of Illinois (the "District Court†) has denied a request ...

Outset Medical (NasdaqGS:OM) Q3 2025 Earnings Call November 10, 2025 04:30 PM ET Speaker1Good day, and thank you for standing by. Welcome to the Outset Medical Q3 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question, please press star 11 on your telephone. You will then hear an automated message: "Advise your hand is raised." To withdraw your question, please press star 11 aga ...

Beyond Air (NasdaqCM:XAIR) Q2 2026 Earnings Call November 10, 2025 04:30 PM ET Speaker1Good afternoon and welcome to the Beyond Air Financial Results Call for the fiscal quarter ended September 30, 2025. At this time, participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. I would like to turn the call over to Garth Russell, LifeSci Advisors. Please go ahead.Speaker2Thank you, Operator. Good afternoon, everyone, and thank you for joining us. Today, after ma ...

QT Imaging Reports Strong Third Quarter 2025 Financial Results Nov 10, 2025 4:50 PM Eastern Standard Time NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (OTCQB: QTIH) ("QT Imaging†or the "Company†), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the three and nine months ended September 30, 2025, and provided a business update. "I am pleased to report that our team delivered another stro ...

Question-and-Answer SessionAnd I guess, maybe, let's start, obviously, Q3 just ended. You guys had another strong quarter. Sales upside raised guidance. Maybe just talk about what's happening out there and remind us where we're falling out for 2025, and then we can start the Q&A.Angela WirickChief Financial Officer Yes. Great third quarter, I'd say, the full year and especially pronounced in the third quarter, showed the strength of our new product launches. Within each franchise, we can look at something v ...

The statements in this presentation regarding expectations of future events or results, including SI-BONE's expectations of continued revenue and procedure growth and financial outlook, are "forward-looking" statements. These forward-looking statements are based on SI-BONE's current expectations and inherently involve significant risks and uncertainties. These risks include SI-BONE's ability to introduce and commercialize new products and indications, SI-BONE's ability to maintain favorable reimbursement fo ...

InfuSystem to Participate at 16th Annual Craig- Hallum Alpha Select Conference on November 18, 2025 Share ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem†or the "Company†),a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today Carrie Lachance, President and Chief Executive Officer and Barry Steele, Chief Financial Officer, will participate in t ...

TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets artificial intelligence (“AI”)-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, is pleased to announce that it has regained exclusive distribution rights for TULSA-PRO® in Canada from Knight Therapeutics Inc. (“Knight”). The TULSA Procedure™, performed using the TULSA-PRO system, is used by ...

Secured $147.6 million in proceeds and committed capital following completion of strategic transactions and concurrent public and private equity offerings, led by $71.6 million in committed capital from Medtronic and Ligand, as well as $30 million from TerumoInitiated patient enrollments in the Virtue Trial evaluating Virtue® Sirolimus AngioInfusion™ Balloon (“Virtue SAB”) trial versus commercially available paclitaxel-coated balloon Demonstrated partnership-driven business model execution with expanded str ...